MARKET NEWS

Treos Bio Announces Positive Interim Results from a Phase 1/2 Clinical Trial
Nanobiotix Announces Launch of Nanotechnology Platform
Up to 6 New HBV Drugs Set to Launch by 2027, With China Driving Market Growth
Pfenex & Alvogen Announce EMA Accepts Marketing Authorization Application
Mereo BioPharma Announces Positive Early 6-Month Data
Fluidigm Introduces Advanta RNA Fusions NGS Library Prep Assay

  FEATURED EDITORIAL

  COMPANY PROFILE

 

JRS Pharma is a leading manufacturer of excipients, offering a complete portfolio of excipient solutions for the pharmaceutical and nutraceutical industries. Our excipients portfolio includes: high functionality excipients, binders, disintegrants, lubricants, functional fillers, thickeners, stabilizers, carriers, and coatings. In addition to our wide range of excipients, we offer excellent technical and formulation support to address the needs of our customers. Our innovative excipients and coatings, along with our formulation expertise, provide our customers with a complete portfolio of solutions for the development and manufacture of solid and liquid dosage forms. Click here for more.

  EXCLUSIVE ONLINE CONTENT

ABITEC Improves Solubility of Topical & Transdermal Applications With Functional Lipid Excipients

ABITEC Improves Solubility of Topical & Transdermal Applications With Functional Lipid Excipients

ABITEC Corporation, a global manufacturer of functional lipid excipients continues to pursue new technologies that solve various formulation challenges in the pharmaceutical market.

Sol-Gel Technologies Announces Seventh Agreement

Sol-Gel Technologies Announces Seventh Agreement

Sol-Gel Technologies, Ltd. recently announced it has entered into a seventh collaborative agreement with Perrigo Israel, an affiliate of Perrigo Company plc for the development, manufacturing, and commercialization of two new generic formulations of antibiotic foams.

Biomunex Pharmaceuticals Establishes US Subsidiary

Biomunex Pharmaceuticals Establishes US Subsidiary

Biomunex Pharmaceuticals recently announced that it has established its US subsidiary, Biomunex Pharmaceuticals Inc., in Cambridge, MA.

Japan’s Medical Device Market Set to Reach .7 Billion in 2025

Japan’s Medical Device Market Set to Reach $74.7 Billion in 2025

The Japanese medical device market is set to reach from $54.5 billion in 2018 to $74.7 billion in 2025, growing at a compound annual growth rate (CAGR) of 4.6% says GlobalData, a leading data and analytics company.

At-a-Glance, a New Way to Visualize Market Data

At-a-Glance, a New Way to Visualize Market Data

Tim McLean, Senior Editor, Life Sciences BCC Research, say his company’s new type of market research report is far shorter — but hopefully it delivers the bigger picture.

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

June 12 – Injection Devices
June 19 – Parenteral Contract Manufacturing